HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Allergy & Immunology
Sys. Review
Vunakizumab may induce severe ulcerative colitis and hepatic enzyme elevation in patients with psoriatic arthritis
Vunakizumab Linked to Severe Ulcerative Colitis in Single Case
This case report and literature review describes a single case of severe ulcerative colitis and hepatic enzyme elevation following vunakizum…
A single case report shows a patient developed severe ulcerative colitis and high liver enzymes after receiving vunakizumab injections.
Frontiers
Sep 4, 2026
Rheumatology
RCT
Vunakizumab improves ASAS20 response in active radiographic axial spondyloarthritis at 16 weeks
New Drug Offers Hope for Ankylosing Spondylitis Patients
This randomized, double-blind, placebo-controlled phase 2 to 3 trial included 548 adults with active r-axSpA in China. At week 16, the vunak…
If you live with the daily stiffness and pain of ankylosing spondylitis, a new treatment option may be on the horizon that works better than…
May 8, 2026